World Obe-Cel Displays Real-World Safety Benefits, Similar Efficacy to Brexu-Cel in R/R ALL December 24, 2025 11:04 am Riley Kandel 0 Min Read SHARE Obe-cel was associated with lower rates of CRS and ICANS vs brexu-cel in relapsed or refractory acute lymphoblastic leukemia. This post was originally published on this site Previous Article Jake Shimabukuro rings in the holidays with ‘Tis The Season’ : World Cafe Words and Music Podcast Next Article ‘Weird Science’ star makes rare appearance since leaving Hollywood after Steven Seagal divorce